<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MCO</journal-id>
<journal-title-group>
<journal-title>Molecular and Clinical Oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9450</issn>
<issn pub-type="epub">2049-9469</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mco.2016.903</article-id>
<article-id pub-id-type="publisher-id">MCO-0-0-903</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Characteristics of colorectal cancer diagnosed with screening abdominal ultrasonography</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>TOMIZAWA</surname><given-names>MINORU</given-names></name>
<xref rid="af1-mco-0-0-903" ref-type="aff">1</xref>
<xref rid="c1-mco-0-0-903" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>SHINOZAKI</surname><given-names>FUMINOBU</given-names></name>
<xref rid="af2-mco-0-0-903" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>HASEGAWA</surname><given-names>RUMIKO</given-names></name>
<xref rid="af3-mco-0-0-903" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>FUGO</surname><given-names>KAZUNORI</given-names></name>
<xref rid="af4-mco-0-0-903" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>SHIRAI</surname><given-names>YOSHINORI</given-names></name>
<xref rid="af3-mco-0-0-903" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>MOTOYOSHI</surname><given-names>YASUFUMI</given-names></name>
<xref rid="af5-mco-0-0-903" ref-type="aff">5</xref></contrib>
<contrib contrib-type="author"><name><surname>SUGIYAMA</surname><given-names>TAKAO</given-names></name>
<xref rid="af6-mco-0-0-903" ref-type="aff">6</xref></contrib>
<contrib contrib-type="author"><name><surname>YAMAMOTO</surname><given-names>SHIGENORI</given-names></name>
<xref rid="af7-mco-0-0-903" ref-type="aff">7</xref></contrib>
<contrib contrib-type="author"><name><surname>KISHIMOTO</surname><given-names>TAKASHI</given-names></name>
<xref rid="af4-mco-0-0-903" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>ISHIGE</surname><given-names>NAOKI</given-names></name>
<xref rid="af8-mco-0-0-903" ref-type="aff">8</xref></contrib>
</contrib-group>
<aff id="af1-mco-0-0-903"><label>1</label>Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<aff id="af2-mco-0-0-903"><label>2</label>Department of Radiology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<aff id="af3-mco-0-0-903"><label>3</label>Department of Surgery, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<aff id="af4-mco-0-0-903"><label>4</label>Department of Molecular Pathology, Chiba University Graduate School of Medicine, Chiba, Chiba 260-8670, Japan</aff>
<aff id="af5-mco-0-0-903"><label>5</label>Department of Neurology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<aff id="af6-mco-0-0-903"><label>6</label>Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<aff id="af7-mco-0-0-903"><label>7</label>Department of Pediatrics, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<aff id="af8-mco-0-0-903"><label>8</label>Department of Neurosurgery, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan</aff>
<author-notes>
<corresp id="c1-mco-0-0-903"><italic>Correspondence to</italic>: Dr Minoru Tomizawa, Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, 934-5 Shikawatashi, Yotsukaido, Chiba 284-0003, Japan, E-mail: <email>nihminor-cib@umin.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>07</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>05</month>
<year>2016</year></pub-date>
<volume>5</volume>
<issue>1</issue>
<fpage>64</fpage>
<lpage>68</lpage>
<history>
<date date-type="received"><day>04</day><month>01</month><year>2016</year></date>
<date date-type="accepted"><day>08</day><month>04</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2016, Spandidos Publications</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Patient records were retrospectively analyzed to elucidate the characteristics of patients with colorectal cancer (CRC) diagnosed with screening abdominal ultrasound (US). Patients diagnosed with CRC using abdominal US [localized irregular wall thickening (W) or a hypoechoic mass with a hyperechoic mass (M)] were enrolled. The patients were subjected to colonoscopy and treated surgically between March, 2010 and January, 2015. A total of 5 men (aged 74.0&#x00B1;0.8 years) and 10 women (aged 73.0&#x00B1;12.0 years) were analyzed. Stratification was analyzed with abdominal US. The threshold value of wall thickness to diagnose CRC was investigated with receiver operating characteristic (ROC) curve analysis. The average wall thickness was 2.8&#x00B1;0.4 mm in the surrounding normal tissue and 12.7&#x00B1;5.2 mm in CRC (one-way analysis of variance, P&#x003C;0.0001). The wall was significantly thicker in CRC compared with the normal colonic wall. The calculated threshold value was 4.3 mm for the diagnosis of CRC. Stratification was preserved in W, while it was lost in M (Chi-squared test, P=0.0196). The hemoglobin concentration was lower, while the C-reactive protein, carcinoembryonic antigen and carbohydrate antigen 19-9 levels were elevated above normal values. The threshold value was 4.3 mm for the diagnosis of CRC with abdominal US.</p>
</abstract>
<kwd-group>
<kwd>receiver operating characteristic curve</kwd>
<kwd>stratification</kwd>
<kwd>contour</kwd>
<kwd>carcinoembryonic antigen</kwd>
<kwd>carbohydrate antigen 19-9</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Colorectal cancer (CRC) is frequently encountered in clinical practice (<xref rid="b1-mco-0-0-903" ref-type="bibr">1</xref>). The majority of CRCs develop slowly from colon polyps, due to the adenoma-carcinoma sequence (<xref rid="b2-mco-0-0-903" ref-type="bibr">2</xref>). To improve the prognosis of patients with CRC, prompt and accurate diagnosis is crucial. CRC is screened with fecal occult blood testing and diagnosed with colonoscopy (<xref rid="b3-mco-0-0-903" ref-type="bibr">3</xref>). However, fecal occult blood testing is not entirely reliable, although no other modalities surpass this test regarding practicality and affordability (<xref rid="b4-mco-0-0-903" ref-type="bibr">4</xref>). Colonoscopy is the gold standard of diagnostic methods for CRC. However, colonoscopy is not available to all patients, as not many clinicians are adequately skilled to perform this procedure (<xref rid="b5-mco-0-0-903" ref-type="bibr">5</xref>).</p>
<p>Abdominal ultrasound (US) is useful for the safe and easy diagnosis of CRC patients (<xref rid="b6-mco-0-0-903" ref-type="bibr">6</xref>&#x2013;<xref rid="b9-mco-0-0-903" ref-type="bibr">9</xref>). CRC is occasionally diagnosed with abdominal US during investigation of patients with abdominal symptoms or anemia (<xref rid="b9-mco-0-0-903" ref-type="bibr">9</xref>). A thickened colonic wall is a clue to the diagnosis of CRC (<xref rid="b10-mco-0-0-903" ref-type="bibr">10</xref>). The threshold value for the diagnosis of CRC, however, has not yet been determined. Stratification and contour illustrated with abdominal US are associated with the depth of invasion, either to the subserosa (SS) or the subserosa (SE) (<xref rid="b11-mco-0-0-903" ref-type="bibr">11</xref>). If stratification and contour are associated with the morphology of CRC, such as wall thickness (W) or mass (M), morphology may designate the depth of invasion (<xref rid="b11-mco-0-0-903" ref-type="bibr">11</xref>).</p>
<p>We retrospectively investigated patient records to determine the characteristics of CRC diagnosed with screening abdominal US. Blood test variables were also analyzed to assess patient backgrounds.</p>
</sec>
<sec sec-type="subjects|methods">
<title>Patients and methods</title>
<sec>
<title/>
<sec>
<title>Ethics statement</title>
<p>This study was approved by the National Hospital Organization Shimoshizu Hospital Ethics Committee. This was not considered to be a clinical trial, as the procedures were performed as a part of routine clinical practice. Written informed consent was obtained from the patients to perform colonoscpy. Informed consent was obtained to perform abdominal US, but written forms were waived. Written informed consent for inclusion in the study was waived, as patient records were anonymized and retrospectively analyzed.</p>
</sec>
<sec>
<title>Patients</title>
<p>The medical records of patients who were treated at the National Hospital Organization Shimoshizu Hospital from March, 2010 to January, 2015 were retrospectively analyzed. Enrolled patients were required to meet the following inclusion criteria: Subjected to abdominal US prior to colonoscopy, computed tomography (CT), or magnetic resonance imaging; underwent surgery at the National Hospital Organization Shimoshisu Hospital; and diagnosis pathologically confirmed. The patients underwent abdominal US for anemia, abdominal pain and bowel obstruction. Certain patients were subjected to abdominal US for screening. Following diagnosis of CRC with abdominal US, colonoscopy was performed in all the patients. The exclusion criteria were as follows: Subjected to abdominal US after the diagnosis of CRC with colonoscopy; subjected to abdominal US with the suspicion of CRC with CT or magnetic resonance imaging; and not subjected to surgery. The enrolled patients were restricted to those whose surgical specimens were available to investigate the depth of invasion. The enrolled patients included 5 men (aged 74.0&#x00B1;0.8 years) and 10 women (aged 73.0&#x00B1;12.0 years).</p>
</sec>
<sec>
<title>Abdominal US</title>
<p>Abdominal US was performed by Senior Fellows of the Japan Society of Ultrasonics in Medicine (M.T. and F.S) using the SSA-700A diagnostic US system (Toshiba Medical Systems Corporation, Ohtawara, Japan) with a 3.75-MHz curved-array probe (PVT-375BT; Toshiba Medical Systems) or an 8.0-MHz linear-array probe (PLT-805AT; Toshiba Medical Systems) in the US unit. The small and large intestines were scanned following routine abdominal US when intestinal diseases, such as ileus, were suspected, or when the patients had anemia.</p>
</sec>
<sec>
<title>Criteria for the diagnosis of CRC</title>
<p>The diagnostic criterion for CRC was localized irregular wall thickening (<xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1A</xref>) or a hypoechoic mass with a hyperechoic mass (pseudokidney sign; <xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1B</xref>) (<xref rid="b10-mco-0-0-903" ref-type="bibr">10</xref>). The former is a common finding in patients with CRC (<xref rid="b12-mco-0-0-903" ref-type="bibr">12</xref>), while the latter represents tumor tissue and air in the residual lumen (<xref rid="b13-mco-0-0-903" ref-type="bibr">13</xref>).</p>
</sec>
<sec>
<title>Wall thickness, shape, stratification and contour of CRC</title>
<p>Wall thickness was measured with abdominal US between the mucosa and serosa borders. Wall thickness was analyzed to differentiate between CRC and the surrounding normal colonic wall. The US findings were evaluated in terms of shape, stratification and contour. Shape was divided into wall thickening (W; <xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1A</xref>) and mass (M; <xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1B</xref>). Stratification was observed due to the different layers of the colonic wall (<xref rid="b12-mco-0-0-903" ref-type="bibr">12</xref>) and patients were divided into two groups, namely preserved (<xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1C</xref>) or lost stratification (<xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1D</xref>). Irregular contour is considered to be an US characteristic of CRC (<xref rid="b10-mco-0-0-903" ref-type="bibr">10</xref>). A proportion of the patients had a smooth contour (<xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1E</xref>), while the majority exhibited irregular contour (<xref rid="f1-mco-0-0-903" ref-type="fig">Fig. 1F</xref>).</p>
</sec>
<sec>
<title>Pathological analysis</title>
<p>The depth of invasion was determined by two pathologists (K.F. and T.K). The analyzed specimens were obtained via surgical resection. Patients referred to other hospitals for pathological analysis and those treated conservatively were excluded from the analysis.</p>
</sec>
<sec>
<title>Blood test variables</title>
<p>The blood test variables analyzed were white blood cell count, hemoglobin (Hb), C-reactive protein (CRP), carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>The mean wall thickness was compared between CRC and the surrounding normal colonic wall with one-way analysis of variance. The Chi-square test was applied to analyze the correlation between the shape of CRC (W or M) and stratification or contour. The Chi-squared test was also applied to analyze the correlation between depth of invasion and the shape of CRC (W or M), stratification, or contour. The threshold value of wall thickness to diagnose CRC was investigated with receiver operating characteristic (ROC) curve analysis. A P-value of &#x003C;0.05 indicated statistically significant differences. JMP 10.0.2 software (SAS Institute, Cary, NC) was used for all statistical analyses.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Comparison of wall thickness between CRC and normal colon</title>
<p>The wall thickness in CRC and in the surrounding normal colonic wall was measured and plotted in <xref rid="f2-mco-0-0-903" ref-type="fig">Fig. 2A</xref>. The average wall thickness was 2.8&#x00B1;0.4 mm in the surrounding normal tissue and 12.7&#x00B1;5.2 mm in CRC. The wall was significantly thicker in CRC compared with the normal colonic wall (P&#x003C;0.0001). The thickness of normal colonic wall was &#x003C;3.0 mm, while it was &#x003E;4.3 mm in CRC. As shown in <xref rid="f2-mco-0-0-903" ref-type="fig">Fig. 2A</xref>, there may be a threshold value for the diagnosis of CRC using wall thickness. ROC curve analysis was performed to investigate the threshold value for the diagnosis of CRC using abdominal US. The calculated threshold value was 4.3 mm. The sensitivity and specificity at this value were both 100&#x0025;.</p>
</sec>
<sec>
<title>Correlation of stratification and contour with shape in CRC</title>
<p>To determine whether there is an association between the shape of CRC and stratification or contour, Chi-square test was performed (<xref rid="tI-mco-0-0-903" ref-type="table">Table I</xref>). Stratification was preserved in W, while it was lost in M (P=0.0196). The correlation between shape and contour was not significant (P=0.4356).</p>
</sec>
<sec>
<title>Correlation of depth of invasion with shape, stratification and contour in CRC</title>
<p>To analyze the association between the depth of invasion and the shape, stratification, or contour, Chi-square test was performed (<xref rid="tII-mco-0-0-903" ref-type="table">Table II</xref>). No significant correlation was observed between any of the variables.</p>
</sec>
<sec>
<title>Laboratory findings in colorectal cancer patients</title>
<p>To assess the background of patients diagnosed with CRC using abdominal US, blood test variables were analyzed (<xref rid="tIII-mco-0-0-903" ref-type="table">Table III</xref>). The Hb level was below the normal range, whereas the CRP, CEA and CA 19-9 levels were above the normal range.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The threshold value of colonic wall thickness on abdominal US may be useful for the diagnosis of CRC. The upper limit of the normal colonic wall is 3 mm on CT (<xref rid="b14-mco-0-0-903" ref-type="bibr">14</xref>). Stermer <italic>et al</italic> performed colonoscopy in patients who had a wall thickened to &#x003E;3 mm (<xref rid="b15-mco-0-0-903" ref-type="bibr">15</xref>). Of the 46 patients, 30 had a wall thicker than 3 mm, but showed no abnormalities, suggesting that false-positive results may be found in patients with walls thicker than 3 mm; thus, the threshold value may be &#x003E;3 mm. In our study, the thickness of normal colonic wall was &#x003C;3 mm. Our data were consistent with previous results (<xref rid="b15-mco-0-0-903" ref-type="bibr">15</xref>). A threshold value for colonic wall thickness has not been determined for the diagnosis of CRC. Our data clearly demonstrated a threshold value of 4.3 mm. The wall thickness in CRC has been reported to be 14 mm at the time of diagnosis with CT (<xref rid="b16-mco-0-0-903" ref-type="bibr">16</xref>), suggesting that the threshold value of wall thickness for the diagnosis of CRC may be lower with abdominal US. This hypothesis may be supported by the fact that abdominal US provides more detailed findings compared with CT (<xref rid="b11-mco-0-0-903" ref-type="bibr">11</xref>).</p>
<p>Loss of stratification is observed in 85&#x0025; of patients with CRC (<xref rid="b12-mco-0-0-903" ref-type="bibr">12</xref>). In our study, stratification was lost in patients with the M type of CRC. CRC is more advanced in the M type compared with the W type. Our data are supported by the fact that loss of stratification indicates CRC cell invasion (<xref rid="b11-mco-0-0-903" ref-type="bibr">11</xref>). Regarding rectal cancer, endorectal US is suitable for the evaluation of the extent and staging of rectal cancer (<xref rid="b17-mco-0-0-903" ref-type="bibr">17</xref>,<xref rid="b18-mco-0-0-903" ref-type="bibr">18</xref>). However, endorectal US is not suitable for screening, in contrast to abdominal US. Moreover, our data clearly indicated that abdominal US was useful for the evaluation of the extent of CRC.</p>
<p>Our data demonstrated that the Hb level was lower and CRP was higher compared with the normal values in patients with CRC. It has been demonstrated that CRC is associated with bleeding and inflammation (<xref rid="b19-mco-0-0-903" ref-type="bibr">19</xref>). An elevated CRP level indicates that CRC is advanced and the prognosis is poor (<xref rid="b20-mco-0-0-903" ref-type="bibr">20</xref>). Lower Hb level is associated with Dukes stages B and C, rather than with stage A (<xref rid="b21-mco-0-0-903" ref-type="bibr">21</xref>). CEA and CA 19-9 are known markers of CRC (<xref rid="b22-mco-0-0-903" ref-type="bibr">22</xref>). Our results demonstrated that the CEA and CA 19-9 levels were higher compared with the normal values. CEA correlates with disease-free survival after surgery for CRC (<xref rid="b23-mco-0-0-903" ref-type="bibr">23</xref>). These results and previous reports suggest that CRC diagnosed with abdominal US is advanced.</p>
<p>The major limitation of our study was the small number of patients, as the enrolled patients were restricted to those diagnosed with CRC using abdominal US.</p>
<p>In conclusion, the threshold value of colonic wall thickness was 4.3 mm for the diagnosis of CRC with abdominal US. CRC was advanced at diagnosis, with higher CRP, CEA and CA 19-9 levels, and lower Hb levels.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-mco-0-0-903"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>H</given-names></name><name><surname>Kloor</surname><given-names>M</given-names></name><name><surname>Pox</surname><given-names>CP</given-names></name></person-group><article-title>Colorectal cancer</article-title><source>Lancet</source><volume>383</volume><fpage>1490</fpage><lpage>1502</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/S0140-6736(13)61649-9</pub-id><pub-id pub-id-type="pmid">24225001</pub-id></element-citation></ref>
<ref id="b2-mco-0-0-903"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Sohaily</surname><given-names>S</given-names></name><name><surname>Biankin</surname><given-names>A</given-names></name><name><surname>Leong</surname><given-names>R</given-names></name><name><surname>Kohonen-Corish</surname><given-names>M</given-names></name><name><surname>Warusavitarne</surname><given-names>J</given-names></name></person-group><article-title>Molecular pathways in colorectal cancer</article-title><source>J Gastroenterol Hepatol</source><volume>27</volume><fpage>1423</fpage><lpage>1431</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1440-1746.2012.07200.x</pub-id><pub-id pub-id-type="pmid">22694276</pub-id></element-citation></ref>
<ref id="b3-mco-0-0-903"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stracci</surname><given-names>F</given-names></name><name><surname>Zorzi</surname><given-names>M</given-names></name><name><surname>Grazzini</surname><given-names>G</given-names></name></person-group><article-title>Colorectal cancer screening: tests, strategies, and perspectives</article-title><source>Front Public Health</source><volume>2</volume><fpage>210</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fpubh.2014.00210</pub-id><pub-id pub-id-type="pmid">25386553</pub-id></element-citation></ref>
<ref id="b4-mco-0-0-903"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benton</surname><given-names>SC</given-names></name><name><surname>Seaman</surname><given-names>HE</given-names></name><name><surname>Halloran</surname><given-names>SP</given-names></name></person-group><article-title>Faecal occult blood testing for colorectal cancer screening: The past or the future</article-title><source>Curr Gastroenterol Rep</source><volume>17</volume><fpage>428</fpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s11894-015-0428-2</pub-id><pub-id pub-id-type="pmid">25673567</pub-id></element-citation></ref>
<ref id="b5-mco-0-0-903"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>MB</given-names></name><name><surname>Kiesslich</surname><given-names>R</given-names></name></person-group><article-title>Advances in endoscopic imaging of colorectal neoplasia</article-title><source>Gastroenterology</source><volume>138</volume><fpage>2140</fpage><lpage>2150</lpage><year>2010</year><pub-id pub-id-type="doi">10.1053/j.gastro.2009.12.067</pub-id><pub-id pub-id-type="pmid">20420951</pub-id></element-citation></ref>
<ref id="b6-mco-0-0-903"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puylaert</surname><given-names>JB</given-names></name><name><surname>van der Zant</surname><given-names>FM</given-names></name><name><surname>Rijke</surname><given-names>AM</given-names></name></person-group><article-title>Sonography and the acute abdomen: Practical considerations</article-title><source>AJR Am J Roentgenol</source><volume>168</volume><fpage>179</fpage><lpage>186</lpage><year>1997</year><pub-id pub-id-type="doi">10.2214/ajr.168.1.8976943</pub-id><pub-id pub-id-type="pmid">8976943</pub-id></element-citation></ref>
<ref id="b7-mco-0-0-903"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam&#x00E9;ris</surname><given-names>W</given-names></name><name><surname>van Randen</surname><given-names>A</given-names></name><name><surname>Dijkgraaf</surname><given-names>MG</given-names></name><name><surname>Bossuyt</surname><given-names>PM</given-names></name><name><surname>Stoker</surname><given-names>J</given-names></name><name><surname>Boermeester</surname><given-names>MA</given-names></name></person-group><article-title>Optimization of diagnostic imaging use in patients with acute abdominal pain (OPTIMA): Design and rationale</article-title><source>BMC Emerg Med</source><volume>7</volume><fpage>9</fpage><year>2007</year><pub-id pub-id-type="doi">10.1186/1471-227X-7-9</pub-id><pub-id pub-id-type="pmid">17683592</pub-id></element-citation></ref>
<ref id="b8-mco-0-0-903"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhillon</surname><given-names>S</given-names></name><name><surname>Halligan</surname><given-names>S</given-names></name><name><surname>Goh</surname><given-names>V</given-names></name><name><surname>Matravers</surname><given-names>P</given-names></name><name><surname>Chambers</surname><given-names>A</given-names></name><name><surname>Remedios</surname><given-names>D</given-names></name></person-group><article-title>The therapeutic impact of abdominal ultrasound in patients with acute abdominal symptoms</article-title><source>Clin Radiol</source><volume>57</volume><fpage>268</fpage><lpage>271</lpage><year>2002</year><pub-id pub-id-type="doi">10.1053/crad.2001.0862</pub-id><pub-id pub-id-type="pmid">12014871</pub-id></element-citation></ref>
<ref id="b9-mco-0-0-903"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomizawa</surname><given-names>M</given-names></name><name><surname>Shinozaki</surname><given-names>F</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Sueishi</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group><article-title>Ultrasonography for leukocytosis or elevated C-reactive protein</article-title><source>Hepatogastroenterology</source><volume>58</volume><fpage>1156</fpage><lpage>1158</lpage><year>2011</year><pub-id pub-id-type="doi">10.5754/hge10606</pub-id><pub-id pub-id-type="pmid">21937369</pub-id></element-citation></ref>
<ref id="b10-mco-0-0-903"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirahama</surname><given-names>M</given-names></name><name><surname>Koga</surname><given-names>T</given-names></name><name><surname>Ishibashi</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Ohta</surname><given-names>Y</given-names></name></person-group><article-title>Sonographic features of colon carcinoma seen with high-frequency transabdominal ultrasound</article-title><source>J Clin Ultrasound</source><volume>22</volume><fpage>359</fpage><lpage>365</lpage><year>1994</year><pub-id pub-id-type="doi">10.1002/jcu.1870220602</pub-id><pub-id pub-id-type="pmid">8071453</pub-id></element-citation></ref>
<ref id="b11-mco-0-0-903"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomizawa</surname><given-names>M</given-names></name><name><surname>Shinozaki</surname><given-names>F</given-names></name><name><surname>Hasegawa</surname><given-names>R</given-names></name><name><surname>Fugo</surname><given-names>K</given-names></name><name><surname>Shirai</surname><given-names>Y</given-names></name><name><surname>Ichiki</surname><given-names>N</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Sueishi</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group><article-title>Screening ultrasonography is useful for the diagnosis of gastric and colorectal cancer</article-title><source>Hepatogastroenterology</source><volume>60</volume><fpage>517</fpage><lpage>521</lpage><year>2013</year><pub-id pub-id-type="pmid">23635445</pub-id></element-citation></ref>
<ref id="b12-mco-0-0-903"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>M</given-names></name><name><surname>Atri</surname><given-names>M</given-names></name><name><surname>Bret</surname><given-names>PM</given-names></name><name><surname>Reinhold</surname><given-names>C</given-names></name><name><surname>Kintzen</surname><given-names>G</given-names></name><name><surname>Thibodeau</surname><given-names>M</given-names></name><name><surname>Aldis</surname><given-names>AE</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name></person-group><article-title>Sonographic appearance of benign and malignant conditions of the colon</article-title><source>AJR Am J Roentgenol</source><volume>170</volume><fpage>1451</fpage><lpage>1455</lpage><year>1998</year><pub-id pub-id-type="doi">10.2214/ajr.170.6.9609152</pub-id><pub-id pub-id-type="pmid">9609152</pub-id></element-citation></ref>
<ref id="b13-mco-0-0-903"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x0027;Malley</surname><given-names>ME</given-names></name><name><surname>Wilson</surname><given-names>SR</given-names></name></person-group><article-title>US of gastrointestinal tract abnormalities with CT correlation</article-title><source>Radiographics</source><volume>23</volume><fpage>59</fpage><lpage>72</lpage><year>2003</year><pub-id pub-id-type="doi">10.1148/rg.231025078</pub-id><pub-id pub-id-type="pmid">12533641</pub-id></element-citation></ref>
<ref id="b14-mco-0-0-903"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>JK</given-names></name></person-group><article-title>Normal colon wall thickness on CT</article-title><source>Radiology</source><volume>145</volume><fpage>415</fpage><lpage>418</lpage><year>1982</year><pub-id pub-id-type="doi">10.1148/radiology.145.2.7134445</pub-id><pub-id pub-id-type="pmid">7134445</pub-id></element-citation></ref>
<ref id="b15-mco-0-0-903"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stermer</surname><given-names>E</given-names></name><name><surname>Lavy</surname><given-names>A</given-names></name><name><surname>Rainis</surname><given-names>T</given-names></name><name><surname>Goldstein</surname><given-names>O</given-names></name><name><surname>Keren</surname><given-names>D</given-names></name><name><surname>Zeina</surname><given-names>AR</given-names></name></person-group><article-title>Incidental colorectal computed tomography abnormalities: Would you send every patient for a colonoscopy?</article-title><source>Can J Gastroenterol</source><volume>22</volume><fpage>758</fpage><lpage>760</lpage><year>2008</year><pub-id pub-id-type="doi">10.1155/2008/901250</pub-id><pub-id pub-id-type="pmid">18818789</pub-id></element-citation></ref>
<ref id="b16-mco-0-0-903"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Ahn</surname><given-names>SJ</given-names></name><name><surname>Jeong</surname><given-names>YM</given-names></name><name><surname>Choi</surname><given-names>HY</given-names></name></person-group><article-title>Evaluation of the growth pattern of carcinoma of colon and rectum by MDCT</article-title><source>Acta Radiol</source><volume>54</volume><fpage>487</fpage><lpage>492</lpage><year>2013</year><pub-id pub-id-type="doi">10.1177/0284185113475923</pub-id><pub-id pub-id-type="pmid">23436826</pub-id></element-citation></ref>
<ref id="b17-mco-0-0-903"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Shin</surname><given-names>SS</given-names></name><name><surname>Jeong</surname><given-names>YY</given-names></name><name><surname>Kang</surname><given-names>HK</given-names></name></person-group><article-title>Multimodal imaging evaluation in staging of rectal cancer</article-title><source>World J Gastroenterol</source><volume>20</volume><fpage>4244</fpage><lpage>4255</lpage><year>2014</year><pub-id pub-id-type="doi">10.3748/wjg.v20.i15.4244</pub-id><pub-id pub-id-type="pmid">24764662</pub-id></element-citation></ref>
<ref id="b18-mco-0-0-903"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Ju</surname><given-names>HX</given-names></name><name><surname>Qian</surname><given-names>CW</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name></person-group><article-title>The value of TRUS in the staging of rectal carcinoma before and after radiotherapy and comparison with the staging postoperative pathology</article-title><source>Clin Radiol</source><volume>69</volume><fpage>481</fpage><lpage>484</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.crad.2013.12.005</pub-id><pub-id pub-id-type="pmid">24517911</pub-id></element-citation></ref>
<ref id="b19-mco-0-0-903"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomizawa</surname><given-names>M</given-names></name><name><surname>Shinozaki</surname><given-names>F</given-names></name><name><surname>Hasegawa</surname><given-names>R</given-names></name><name><surname>Togawa</surname><given-names>A</given-names></name><name><surname>Shirai</surname><given-names>Y</given-names></name><name><surname>Ichiki</surname><given-names>N</given-names></name><name><surname>Motoyoshi</surname><given-names>Y</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Sueishi</surname><given-names>M</given-names></name></person-group><article-title>Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding</article-title><source>World J Gastroenterol</source><volume>20</volume><fpage>1311</fpage><lpage>1317</lpage><year>2014</year><pub-id pub-id-type="doi">10.3748/wjg.v20.i5.1311</pub-id><pub-id pub-id-type="pmid">24574805</pub-id></element-citation></ref>
<ref id="b20-mco-0-0-903"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibutani</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Nagahara</surname><given-names>H</given-names></name><name><surname>Ohtani</surname><given-names>H</given-names></name><name><surname>Sugano</surname><given-names>K</given-names></name><name><surname>Ikeya</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Amano</surname><given-names>R</given-names></name><name><surname>Kubo</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><etal/></person-group><article-title>Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer</article-title><source>Hepatogastroenterology</source><volume>61</volume><fpage>2236</fpage><lpage>2240</lpage><year>2014</year><pub-id pub-id-type="pmid">25699359</pub-id></element-citation></ref>
<ref id="b21-mco-0-0-903"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanbhai</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>M</given-names></name><name><surname>Cantanhede</surname><given-names>G</given-names></name><name><surname>Ilyas</surname><given-names>S</given-names></name><name><surname>Richards</surname><given-names>T</given-names></name></person-group><article-title>The problem of anaemia in patients with colorectal cancer</article-title><source>ISRN Hematol</source><volume>2014</volume><fpage>547914</fpage><year>2014</year><pub-id pub-id-type="doi">10.1155/2014/547914</pub-id><pub-id pub-id-type="pmid">24696785</pub-id></element-citation></ref>
<ref id="b22-mco-0-0-903"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stiksma</surname><given-names>J</given-names></name><name><surname>Grootendorst</surname><given-names>DC</given-names></name><name><surname>van der Linden</surname><given-names>PW</given-names></name></person-group><article-title>CA 19-9 as a marker in addition to CEA to monitor colorectal cancer</article-title><source>Clin Colorectal Cancer</source><volume>13</volume><fpage>239</fpage><lpage>244</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.clcc.2014.09.004</pub-id><pub-id pub-id-type="pmid">25442815</pub-id></element-citation></ref>
<ref id="b23-mco-0-0-903"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li Destri</surname><given-names>G</given-names></name><name><surname>Rubino</surname><given-names>AS</given-names></name><name><surname>Latino</surname><given-names>R</given-names></name><name><surname>Giannone</surname><given-names>F</given-names></name><name><surname>Lanteri</surname><given-names>R</given-names></name><name><surname>Scilletta</surname><given-names>B</given-names></name><name><surname>Di Cataldo</surname><given-names>A</given-names></name></person-group><article-title>Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable</article-title><source>Int Surg</source><volume>100</volume><fpage>617</fpage><lpage>625</lpage><year>2015</year><pub-id pub-id-type="doi">10.9738/INTSURG-D-14-00100.1</pub-id><pub-id pub-id-type="pmid">25875542</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mco-0-0-903" position="float">
<label>Figure 1.</label>
<caption><p>Morphological characteristics of colorectal cancer (CRC). CRCs were divided into two groups according to the morphological findings. The shape of CRC was classified as (A) wall thickening or (B) mass. Stratification was classified as (C) preserved (arrow) or (D) lost (arrowhead). The contour of the surface of the serosa in CRC (asterisks) was classified as (E) smooth or (F) irregular.</p></caption>
<graphic xlink:href="mco-05-01-0064-g00.tif"/>
</fig>
<fig id="f2-mco-0-0-903" position="float">
<label>Figure 2.</label>
<caption><p>Scattered plot and receiver operating characteristic (ROC) curve analysis of wall thickness in colorectal cancer (CRC). (A) Wall thickness in CRC and the surrounding normal colonic wall. (B) The ROC curve corresponds to the vertical axis and upper limit line. The broken line shows the reference line.</p></caption>
<graphic xlink:href="mco-05-01-0064-g01.jpg"/>
</fig>
<table-wrap id="tI-mco-0-0-903" position="float">
<label>Table I.</label>
<caption><p>Correlation of the stratification or contour with the shape of colorectal cancers.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2">Stratification (P=0.0196)</th>
<th align="center" valign="bottom" colspan="2">Contour (P=0.4356)</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th align="center" valign="bottom" colspan="2"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Shape</th>
<th align="center" valign="bottom">Preserved</th>
<th align="center" valign="bottom">Lost</th>
<th align="center" valign="bottom">Smooth</th>
<th align="center" valign="bottom">Irregular</th>
<th align="center" valign="bottom">Total</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">W</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">&#x00A0;&#x00A0;4</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">&#x00A0;&#x00A0;5</td>
<td align="center" valign="top">&#x00A0;&#x00A0;7</td>
</tr>
<tr>
<td align="left" valign="top">M</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x00A0;&#x00A0;8</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">&#x00A0;&#x00A0;7</td>
<td align="center" valign="top">&#x00A0;&#x00A0;8</td>
</tr>
<tr>
<td align="left" valign="top">Total</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">15</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mco-0-0-903"><p>The correlation was analyzed with the Chi-square test. W, wall thickening; M, mass.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-mco-0-0-903" position="float">
<label>Table II.</label>
<caption><p>Correlation of depth of invasion of colorectal cancer with shape, stratification and contour.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2">W or M (P=0.1292)</th>
<th align="center" valign="bottom" colspan="2">Stratification (P=0.1225)</th>
<th align="center" valign="bottom" colspan="2">Contour (P=0.4686)</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th align="center" valign="bottom" colspan="2"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Depth of invasion</th>
<th align="center" valign="bottom">W</th>
<th align="center" valign="bottom">M</th>
<th align="center" valign="bottom">Preserved</th>
<th align="center" valign="bottom">Lost</th>
<th align="center" valign="bottom">Smooth</th>
<th align="center" valign="bottom">Irregular</th>
<th align="center" valign="bottom">Total</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">MP</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">&#x00A0;&#x00A0;0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x00A0;&#x00A0;1</td>
<td align="center" valign="top">&#x00A0;&#x00A0;1</td>
</tr>
<tr>
<td align="left" valign="top">SS</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">&#x00A0;&#x00A0;9</td>
<td align="center" valign="top">12</td>
</tr>
<tr>
<td align="left" valign="top">SE</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2</td>
<td align="center" valign="top">&#x00A0;&#x00A0;2</td>
</tr>
<tr>
<td align="left" valign="top">Total</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">15</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-mco-0-0-903"><p>The correlations were analyzed with the Chi-square test. W, wall thickening; M, mass; MP, invasion of the muscularis propria; SS, invasion of the subserosa; SE, invasion beyond the serosa.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-mco-0-0-903" position="float">
<label>Table III.</label>
<caption><p>Laboratory findings in colorectal cancer patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Findings</th>
<th align="center" valign="bottom">Range</th>
<th align="center" valign="bottom">Mean &#x00B1; SD</th>
<th align="center" valign="bottom">Normal</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">WBC (&#x00D7;10<sup>3</sup>/&#x00B5;l)</td>
<td align="center" valign="top">3.1&#x2013;19.0</td>
<td char="&#x00B1;" align="char" valign="top">8.0&#x00B1;4.5</td>
<td align="center" valign="top">3.5&#x2013;8.5</td>
</tr>
<tr>
<td align="left" valign="top">Hb (g/dl)</td>
<td align="center" valign="top">3.9&#x2013;14.7</td>
<td char="&#x00B1;" align="char" valign="top">10.8&#x00B1;5.3</td>
<td align="center" valign="top">11.5&#x2013;15.0</td>
</tr>
<tr>
<td align="left" valign="top">CRP (mg/dl)</td>
<td align="center" valign="top">0.2&#x2013;14.1</td>
<td char="&#x00B1;" align="char" valign="top">4.2&#x00B1;5.3</td>
<td align="center" valign="top">0&#x2013;0.3</td>
</tr>
<tr>
<td align="left" valign="top">CEA (ng/ml)</td>
<td align="center" valign="top">1.5&#x2013;44.2</td>
<td char="&#x00B1;" align="char" valign="top">18.9&#x00B1;17.9</td>
<td align="center" valign="top">0&#x2013;5</td>
</tr>
<tr>
<td align="left" valign="top">CA19&#x2013;9 (U/ml)</td>
<td align="center" valign="top">5.3&#x2013;595</td>
<td char="&#x00B1;" align="char" valign="top">63.2&#x00B1;168</td>
<td align="center" valign="top">0&#x2013;37</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-mco-0-0-903"><p>SD, standard deviation; WBC, white blood cell count; Hb, hemoglobin; CRP, C-reactive protein; CEA, carcinoembryonic antigen; CA 19&#x2013;9, carbohydrate antigen 19&#x2013;9.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
